Viewing Study NCT01861002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-06-30 @ 12:30 AM
Study NCT ID: NCT01861002
Status: COMPLETED
Last Update Posted: 2021-06-09
First Post: 2013-05-21
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoblastic Leukemia, Acute, Childhood View
None Myelogenous Leukemia, Acute, Childhood View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapse View
None Lymphoblastic View
None Leukemia View
None Azacytidine View
None Refractory View
None Myelogenous View
None Acute View
None Childhood View
None Pediatric View
None ALL View
None AML View
None Methylation View
None Epigenetic therapy View